Literature DB >> 15265442

[Efficacy of sublingual polyvalent bacterial vaccine (Lantigen B) in children with recurrent respiratory infection: a randomized double-blind controlled clinical trial].

Ai-huan Chen, Rong-chang Chen, Chun-qing Zhang, Denui Chen, Sui Huang, Yunen Lin, Jieyi Zhan, Nanshan Zhong.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15265442

Source DB:  PubMed          Journal:  Zhonghua Er Ke Za Zhi        ISSN： 0578-1310


× No keyword cloud information.
  2 in total

1.  The bacterial lysate Lantigen B reduces the number of acute episodes in patients with recurrent infections of the respiratory tract: the results of a double blind, placebo controlled, multicenter clinical trial.

Authors:  Fulvio Braido; Giovanni Melioli; Piero Candoli; Andrea Cavalot; Mario Di Gioacchino; Vittorio Ferrero; Cristoforo Incorvaia; Carlo Mereu; Erminia Ridolo; Giovanni Rolla; Oliviero Rossi; Eleonora Savi; Libero Tubino; Giorgio Reggiardo; Ilaria Baiardini; Eddi di Marco; Gilberto Rinaldi; Giorgio Walter Canonica; Carlo Accorsi; Claudia Bossilino; Laura Bonzano; Michela DiLizia; Barbara Fedrighini; Valentina Garelli; Vincenzo Gerace; Sara Maniscalco; Ilaria Massaro; Alessandro Messi; Manlio Milanese; Silvia Peveri; Arminio Penno; Stefano Pizzimenti; Tiziana Pozzo; Alberto Raie; Sergio Regina; Francesca Sclifò
Journal:  Immunol Lett       Date:  2014-11-03       Impact factor: 3.685

Review 2.  Immunostimulants for preventing respiratory tract infection in children: A systematic review and meta-analysis.

Authors:  Arturo Berber; Blanca Estela Del-Río-Navarro; Nayely Reyes-Noriega; Juan José Luis Sienra-Monge
Journal:  World Allergy Organ J       Date:  2022-09-14       Impact factor: 5.516
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.